These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 26045135)

  • 1. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.
    Benesic A; Leitl A; Gerbes AL
    Gut; 2016 Sep; 65(9):1555-63. PubMed ID: 26045135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug-Induced Liver Injury.
    Benesic A; Rotter I; Dragoi D; Weber S; Leitl A; Buchholtz ML; Gerbes AL
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1488-1494.e5. PubMed ID: 29723689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
    Teschke R; Danan G
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Drug Combinations Can Enhance Toxicity as Shown by Monocyte-Derived Hepatocyte-like Cells From Patients With Idiosyncratic Drug-Induced Liver Injury.
    Benesic A; Jalal K; Gerbes AL
    Toxicol Sci; 2019 Oct; 171(2):296-302. PubMed ID: 31407002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-Derived Hepatocyte-Like Cell Test: A Novel Tool for in vitro Identification of Drug-Induced Liver Injury in Patients with Herbal or Dietary Supplements.
    Weber S; Wong GLH; Wong VWS; Benesic A; Chan HLY; Gerbes AL
    Digestion; 2021; 102(4):650-653. PubMed ID: 32690854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.
    Teschke R; Danan G
    Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400
    [No Abstract]   [Full Text] [Related]  

  • 7. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.
    Cheetham TC; Lee J; Hunt CM; Niu F; Reisinger S; Murray R; Powell G; Papay J
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):601-8. PubMed ID: 24920207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method.
    Teschke R; Danan G
    Medicines (Basel); 2024 Apr; 11(4):. PubMed ID: 38667507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causality assessment in drug-induced liver injury.
    Hayashi PH
    Semin Liver Dis; 2009 Nov; 29(4):348-56. PubMed ID: 19826968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies.
    Teschke R; Danan G
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
    Teschke R; Schulze J; Eickhoff A; Danan G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LiverTox Paradox-Gaps between Promised Data and Reality Check.
    Teschke R; Danan G
    Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUCAM in Drug and Herb Induced Liver Injury: The Update.
    Danan G; Teschke R
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.
    Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D
    Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implications.
    Watkins PB
    Adv Pharmacol; 2019; 85():165-193. PubMed ID: 31307586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causality assessment for suspected DILI during clinical phases of drug development.
    Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
    Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Induced Liver Injury: Highlights of the Recent Literature.
    Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
    Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
    Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
    Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
    Hadi M; Chen Y; Starokozhko V; Merema MT; Groothuis GM
    Chem Res Toxicol; 2012 Sep; 25(9):1938-47. PubMed ID: 22870868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.